Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for ARDS (STAR)
NCT02326350Phase 2Terminated
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Feb 2015
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing Aspirin 75mg with Placebo (2 arms). Primary endpoint: Oxygenation Index (OI) at Day 7. Started Feb 2015; status: terminated.
02
Drugs
aspirin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02326350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326350.